IR@PKUHSC  > 北京大学公共卫生学院
学科主题公共卫生
Clinical progression and predictors of death in patients with severe fever with thrombocytopenia syndrome in China
Cui, Ning1; Bao, Xiao-Lei2; Yang, Zhen-Dong1; Lu, Qing-Bin3; Hu, Chun-Yan4; Wang, Li-Yuan4,5; Wang, Bing-Jun1; Wang, Hong-Yu4,5; Liu, Kun4; Yuan, Chun1; Fan, Xue-Juan1; Wang, Zhen1; Zhang, Lan1; Zhang, Xiao-Ai4; Hu, Liang-Ping2; Liu, Wei4; Cao, Wu-Chun4
关键词Sfts Clinical Progression Predictors Of Death
刊名JOURNAL OF CLINICAL VIROLOGY
2014
DOI10.1016/j.jcv.2013.10.024
59期:1页:12-17
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Virology
研究领域[WOS]Virology
关键词[WOS]TO-PERSON TRANSMISSION ; SYNDROME BUNYAVIRUS ; SYNDROME VIRUS ; DISEASE ; PATHOGENESIS ; DIAGNOSIS ; CONTACT ; CLUSTER ; BLOOD
英文摘要

Background: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease of which the clinical progression and factors related to death are still unclear.

Objective: To identify the clinical progression of SFTS and explore predictors of fatal outcome throughout the disease progress.

Study design: A prospective study was performed in a general hospital located in Xinyang city during 2011-2013. Confirmed SFTS patients were recruited and laboratory parameters that were commonly evaluated in clinical practice were collected. The clinical progression was determined based on analysis of dynamic profiles and Friedman′s test. At each clinical stage, the laboratory features that could be used to predict fatal outcome of SFTS patients were identified by stepwise discriminant analysis.

Results: Totally 257 survivors and 54 deceased SFTS patients were recruited and the data of 11 clinical and laboratory parameters along their entire disease course were consecutively collected. Three clinical stages (day 1-5 post onset, day 6-11 post onset and day 12 to hospital discharge) were determined based on distinct clinical parameters evaluations. Multivariate discriminant analysis at each clinical stage disclosed the indicators of the fatal outcome as decreased platelet counts at early stage, older age and increased AST level at middle stage, and decreased lymphocyte percentage and increased LDH level at late stage.

Conclusions: The significant indicators at three clinical stages could be used to assist identifying the patients with high risk of death. This knowledge might help to perform supportive treatment and avoid fatality. (C) 2013 Elsevier B.V. All rights reserved.

语种英语
WOS记录号WOS:000329408700003
项目编号81222037 ; 81290344 ; 81130086 ; 81072250 ; 2013ZX10004-202
资助机构Natural Science Foundation of China ; China Mega-Project for Infectious Diseases grant
引用统计
被引频次:21[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/56433
专题北京大学公共卫生学院
北京大学公共卫生学院_公共卫生学院
作者单位1.Anhui Med Univ, Grad Sch, Hefei, Peoples R China
2.Peoples Liberat Army, Hosp 154, Xinyang 464000, Peoples R China
3.Peking Univ, Sch Publ Hlth, Beijing 100191, Peoples R China
4.Acad Mil Med Sci, Consulting Ctr Biomed Stat, Beijing 100850, Peoples R China
5.Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China
推荐引用方式
GB/T 7714
Cui, Ning,Bao, Xiao-Lei,Yang, Zhen-Dong,et al. Clinical progression and predictors of death in patients with severe fever with thrombocytopenia syndrome in China[J]. JOURNAL OF CLINICAL VIROLOGY,2014,59(1):12-17.
APA Cui, Ning.,Bao, Xiao-Lei.,Yang, Zhen-Dong.,Lu, Qing-Bin.,Hu, Chun-Yan.,...&Cao, Wu-Chun.(2014).Clinical progression and predictors of death in patients with severe fever with thrombocytopenia syndrome in China.JOURNAL OF CLINICAL VIROLOGY,59(1),12-17.
MLA Cui, Ning,et al."Clinical progression and predictors of death in patients with severe fever with thrombocytopenia syndrome in China".JOURNAL OF CLINICAL VIROLOGY 59.1(2014):12-17.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Cui, Ning]的文章
[Bao, Xiao-Lei]的文章
[Yang, Zhen-Dong]的文章
百度学术
百度学术中相似的文章
[Cui, Ning]的文章
[Bao, Xiao-Lei]的文章
[Yang, Zhen-Dong]的文章
必应学术
必应学术中相似的文章
[Cui, Ning]的文章
[Bao, Xiao-Lei]的文章
[Yang, Zhen-Dong]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。